Searched for
COVID 19 THERAPEUTICS
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- India sends emergency medical supplies for Ebola outbreak response in CongoIndia has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- India among 8 nations seeking 5-year patent waiver for Covid diagnosticsIn a submission to the World Trade Organization, they said that diagnostics and therapeutics are "essential tools for a comprehensive appro...
- WTO Council defers decision on TRIPS waiver extension"In view of paragraph 8 of the ministerial decision on the TRIPS Agreement adopted on June 17, 2022 providing that no later than six months...
- India, 82 others for changes in draft report of WTOAt an informal Trade-related Aspects of Intellectual Property Rights (TRIPS) Council meeting of the WTO on Thursday, they said the decision...
- India wants 5-year IPR waiver on Covid tests, treatmentsAt a meeting of the Trade-related Aspects of Intellectual Property Rights (TRIPS) Council on Tuesday, India and others submitted a text pro...
- US delays patent waiver deal for Covid diagnostics, therapeuticsThe 12th Ministerial Conference decision of the World Trade Organization (WTO) contains a commitment that no later than six months from the...
- India, 82 others for extension of Covid vaccine patent waiverAt a meeting of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) on Wednesday, three divergent positions emerg...
- Pfizer to boost pipeline with $5.4 bln Global Blood Therapeutics buyNew York-based Pfizer, flush with cash from sales of its COVID-19 vaccine last year, has been on the lookout for acquisitions that could br...
- Concerns raised over 10% vaccine export clause at TRIPS meetSources said discussions on the proposal will continue as some countries like the UK said the proposal is not endorsed by any member and it...
- Drugs for treating diabetes, obesity & ageing can potentially be used to treat Covid: ResearchersThe scientists believe that natural compounds such as curcumin and resveratrol, among others, and existing drugs such as metformin and Rapa...
- Dr. Reddy's Laboratories announces commercial launch of COVID-19 drug 2-DGIn the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand covera...
- Act on shortage of Covid drugs, tooOn top of a shortage of medical oxygen in the places that need them most, reports emerge of a shortage of assorted drugs used in the treatm...
- WTO to take up India, South Africa's TRIPS waiver pleaThe proposed game-changing waiver of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) would enable free flow ...
- Ayush Ministry to take up clinical study on potential of Vasa, Guduchi for management of COVID-19This will be a randomized, open label three armed study, and will be conducted at the All India Institute of Ayurveda (AIIA), New Delhi, in...
- Looking at 'repurposing' drugs: BioconWe are working to repurpose our novel monoclonal antibody Itolizumab (used in psoriasis) to treat complications caused by Covid-19 infectio...
Load More
